Check-Cap Ltd. (CHEK)

NASDAQ: CHEK · Real-Time Price · USD
0.8193
-0.0607 (-6.90%)
At close: May 9, 2025, 4:00 PM
0.8592
+0.0399 (4.87%)
After-hours: May 9, 2025, 7:38 PM EDT
-6.90%
Market Cap 4.79M
Revenue (ttm) n/a
Net Income (ttm) -12.56M
Shares Out 5.85M
EPS (ttm) -2.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,517
Open 0.8850
Previous Close 0.8800
Day's Range 0.8041 - 0.8850
52-Week Range 0.5600 - 3.0400
Beta 0.23
Analysts n/a
Price Target n/a
Earnings Date May 20, 2025

About CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application tha... [Read more]

Sector Healthcare
IPO Date Feb 19, 2015
Employees 85
Stock Exchange NASDAQ
Ticker Symbol CHEK
Full Company Profile

Financial Performance

Financial Statements

News

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

Believes Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Truste...

1 day ago - PRNewsWire

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Proposed business combination to create a North American technology company with an AI-driven fintech marketplace. Combined company to apply for listing on Nasdaq and TSX TORONTO , March 25, 2024 /PRN...

1 year ago - PRNewsWire

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

TORONTO , Dec. 22, 2023 /PRNewswire/ - Symetryx Corporation ("Symetryx"), a Canadian venture company, is pleased to announce that the shareholders of Check-Cap Ltd. (NASDAQ: CHEK) voted overwhelmingly...

1 year ago - PRNewsWire

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

SYMETRYX RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER SYMETRYX RECOMMENDS VOTING FOR THEIR QUALIFIED INDEPENDENT BOARD NOMINEES TIME IS SHORT - THE VOTE DEADLINE IS 11:59 pm EST THURSDAY DECEM...

1 year ago - PRNewsWire

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

TORONTO , Dec. 8, 2023 /PRNewswire/ - Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to VOTE AGAINST  ...

1 year ago - PRNewsWire

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

TORONTO , Dec. 5, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") once again encourages our fellow shareholders of Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) to review the news release i...

1 year ago - PRNewsWire

Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

Recommends Fellow Shareholders Vote AGAINST Keystone Transaction & the Check-Cap Board Nominees - Further Recommends a Vote FOR the Symetryx Slate of Director Candidates Cites Unrealistic and Aggressi...

1 year ago - PRNewsWire

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Q3 revenue increased 18.9% year-over-year to $16.8M, including $11.9M from the U.S. Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Mee...

1 year ago - GlobeNewsWire

Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual  General Meeting on Monday, December 18 th ISFIYA, Israel , Nov. 27, 2023 /PRNewswire/ -- Check...

1 year ago - PRNewsWire

Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone's comprehensive portfolio of implants, a...

1 year ago - GlobeNewsWire

Check-Cap Reports Second Quarter 2023 Financial Results

ISFIYA, Israel, Aug. 4, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK),  today announced financial results for the second quarter and six months ended June 30, 2023.

1 year ago - PRNewsWire

SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

TORONTO, ON , July 25, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announced an increase in price per share for our non-binding proposal to acquire common shares of Check-Cap LTD (NAS...

1 year ago - PRNewsWire

Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce

ISFIYA, Israel , June 6, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) today announced that following a review of its business, resources and capabilities, it is ex...

2 years ago - PRNewsWire

Check-Cap Reports First Quarter 2023 Financial Results

ISFIYA, Israel , May 11, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first...

2 years ago - PRNewsWire

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results

ISFIYA, Israel , March 31, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of...

2 years ago - PRNewsWire

Check-Cap Issues an Update to Shareholders

ISFIYA, Israel , March 21, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of...

2 years ago - PRNewsWire

Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

ISFIYA, Israel , Nov. 30, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

2 years ago - PRNewsWire

Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

ISFIYA, Israel , Aug. 31, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

2 years ago - PRNewsWire

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

ISFIYA, Israel , June 23, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

3 years ago - PRNewsWire

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel , June 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a ...

3 years ago - PRNewsWire

Check-Cap Announces Initiation of the U.S. Pivotal Trial

ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

3 years ago - PRNewsWire

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (N...

3 years ago - PRNewsWire

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

ISFIYA, Israel, March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

3 years ago - PRNewsWire

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

The FDA has approved Check-Cap Ltd's (NASDAQ: CHEK) amended Investigational Device Exemption (IDE) application to initiate the U.S. pivotal study of C-Scan. The U.S. pivotal study consists of two part...

3 years ago - Benzinga

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

ISFIYA, Israel, Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

3 years ago - PRNewsWire